Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 13/20 | 0.40 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | CUL4A | Q13619 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25983090 | 0.85 | AR (0.46) | ARPDK2TSHR | |
| SCHEMBL29295870 | 0.80 | CYP3A4 (0.47) | CYP1A2CYP3A4CYP2C9CYP2C19AR | |
| SCHEMBL5794355 | 0.78 | TSHR (0.43) | CYP1A2CYP3A4CYP2C9CYP2C19PDK2 | |
| SCHEMBL1994873 | 0.78 | AR (0.41) | ARPDK2CUL4ATSHR | |
| SCHEMBL3911267 | 0.78 | AR (0.46) | AR | |
| SCHEMBL29378798 | 0.78 | AR (0.41) | ARPDK2CUL4ATSHR | |
| SCHEMBL16954302 | 0.76 | AR (0.40) | ARPDK2TSHR | |
| SCHEMBL16960191 | 0.76 | AR (0.40) | ARPDK2TSHR | |
| SCHEMBL14699104 | 0.76 | DYRK1A (0.42) | ARPDK2TSHR | |
| SCHEMBL2658869 | 0.76 | AR (0.40) | ARPDK2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117229170-A | Anti-androgenic drug intermediate and synthetic method and application thereof | 常熟泓德生物科技有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-105330554-A | Synthesis method of chiral cyclopropylacetylenyl tert-alcohol compound | SHANGHAI DESANO PHARMACEUTICAL INVEST CO LTD | 2016-02-17 | — | — | CN | claimed |
| CN-117229170-A | Anti-androgenic drug intermediate and synthetic method and application thereof | 常熟泓德生物科技有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-117229170-A | Anti-androgenic drug intermediate and synthetic method and application thereof | 常熟泓德生物科技有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-104803916-B | Hete rocyclic derivatives as SARM (SARMS) | 詹森药业有限公司 | 2017-08-11 | — | — | CN | disclosed |
| CN-104016924-B | A kind of \" one kettle way \" synthesizes grace and to mix the method for Shandong amine | Shanghai Ding Ya pharmaceutical chemistry Science and Technology Ltd. (CN) | 2016-04-13 | — | — | CN | disclosed |
| CN-105330554-A | Synthesis method of chiral cyclopropylacetylenyl tert-alcohol compound | SHANGHAI DESANO PHARMACEUTICAL INVEST CO LTD | 2016-02-17 | — | — | CN | disclosed |
| CN-1810775-B | Preparation process of 4-amino-2-trifluoromethyl benzonitrile | BAOQING TANG | 2012-05-09 | — | — | CN | disclosed |
| EP-2416657-A1 | SUBSTITUTED DI-ARYLHYDANTOIN AND DI-ARYLTHIOHYDANTOIN COMPOUNDS AND METHODS FOR USE THEREOF | Medivation Prostate Therapeutics, Inc. (US) | 2012-02-15 | — | — | EP | disclosed |
| WO-2010118354-A1 | SUBSTITUTED DI-ARYLHYDANTOIN AND DI-ARYLTHIOHYDANTOIN COMPOUNDS AND METHODS FOR USE THEREOF | MEDIVATION PROSTATE THERAPEUTICS, INC. (US) | 2010-10-14 | — | — | WO | disclosed |
| CN-1810775-A | Novel method for preparing 4-amino-2-trifluoromethyl benzonitrile | TANG BAOQING (CN) | 2006-08-02 | — | — | CN | disclosed |
| EP-1669347-A1 | Process for the preparation of 3-¬(4-fluorophenyl) sulfonyl|-2-hydroxy-2-methyl propionic acid | Helm AG (DE) | 2006-06-14 | — | — | EP | disclosed |